117 related articles for article (PubMed ID: 29885441)
1. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.
Chen W; Chen S; Chen W; Li XC; Ghobrial RM; Kloc M
Transpl Immunol; 2018 Oct; 50():15-25. PubMed ID: 29885441
[TBL] [Abstract][Full Text] [Related]
2. Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.
Liu Y; Chen W; Wu C; Minze LJ; Kubiak JZ; Li XC; Kloc M; Ghobrial RM
J Heart Lung Transplant; 2017 Mar; 36(3):340-354. PubMed ID: 27692539
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119).
Subuddhi A; Uosef A; Zou D; Ubelaker HV; Ghobrial RM; Kloc M
Int Immunopharmacol; 2023 May; 118():110017. PubMed ID: 36931169
[TBL] [Abstract][Full Text] [Related]
4. ROCK inhibition impedes macrophage polarity and functions.
Liu Y; Tejpal N; You J; Li XC; Ghobrial RM; Kloc M
Cell Immunol; 2016 Feb; 300():54-62. PubMed ID: 26711331
[TBL] [Abstract][Full Text] [Related]
5. A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model.
Ohki S; Iizuka K; Ishikawa S; Kano M; Dobashi K; Yoshii A; Shimizu Y; Mori M; Morishita Y
J Heart Lung Transplant; 2001 Sep; 20(9):956-63. PubMed ID: 11557190
[TBL] [Abstract][Full Text] [Related]
6. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.
Poosti F; Yazdani S; Dolman ME; Kok RJ; Chen C; Ding G; Lacombe M; Prakash J; van den Born J; Hillebrands JL; van Goor H; de Borst MH
Eur J Pharmacol; 2012 Nov; 694(1-3):111-9. PubMed ID: 22964464
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil regulates the macrophage skewing and ameliorates myofibroblasts by inhibition of RhoA/Rho-kinase signalling in infarcted rats.
Lee TM; Lin SZ; Chang NC
J Cell Mol Med; 2018 Feb; 22(2):1056-1069. PubMed ID: 29119680
[TBL] [Abstract][Full Text] [Related]
9. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
10. Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model.
Kubo K; Kawato Y; Nakamura K; Nakajima Y; Nakagawa TY; Hanaoka K; Oshima S; Fukahori H; Inami M; Morokata T; Higashi Y
Eur J Pharmacol; 2018 Nov; 838():145-152. PubMed ID: 30196110
[TBL] [Abstract][Full Text] [Related]
11. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
12. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
Eisa-Beygi S; Wen XY
Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod (FTY720) prevents chronic rejection of rodent cardiac allografts through inhibition of the RhoA pathway.
Chen W; Chen W; Chen S; Uosef A; Ghobrial RM; Kloc M
Transpl Immunol; 2021 Apr; 65():101347. PubMed ID: 33131698
[TBL] [Abstract][Full Text] [Related]
14. Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex.
Chen W; Zhao Y; Li XC; Kubiak JZ; Ghobrial RM; Kloc M
Int J Biochem Cell Biol; 2017 Dec; 93():12-24. PubMed ID: 29061365
[TBL] [Abstract][Full Text] [Related]
15. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway.
Cheng CI; Chen PH; Lin YC; Kao YH
Cell Signal; 2015 Feb; 27(2):283-92. PubMed ID: 25446262
[TBL] [Abstract][Full Text] [Related]
16. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
Antoniu SA
Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise training and RhoA/ROCK inhibition on plaque in ApoE-/- mice.
Matsumoto A; Manthey HD; Marsh SA; Fassett RG; de Haan JB; Rolfe BE; Coombes JS
Int J Cardiol; 2013 Aug; 167(4):1282-8. PubMed ID: 22525349
[TBL] [Abstract][Full Text] [Related]
18. Dissonant response of M0/M2 and M1 bone-marrow-derived macrophages to RhoA pathway interference.
Liu Y; Chen W; Minze LJ; Kubiak JZ; Li XC; Ghobrial RM; Kloc M
Cell Tissue Res; 2016 Dec; 366(3):707-720. PubMed ID: 27628094
[TBL] [Abstract][Full Text] [Related]
19. Role of p38, ERK1/2, focal adhesion kinase, RhoA/ROCK and cytoskeleton in the adipogenesis of human mesenchymal stem cells.
Xu B; Ju Y; Song G
J Biosci Bioeng; 2014 May; 117(5):624-31. PubMed ID: 24331979
[TBL] [Abstract][Full Text] [Related]
20. Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis.
Lescoat A; Ballerie A; Lelong M; Augagneur Y; Morzadec C; Jouneau S; Jégo P; Fardel O; Vernhet L; Lecureur V
Front Immunol; 2020; 11():219. PubMed ID: 32133004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
